Document is current
Any future updates will be listed below
-
Authors
- License Information
-
More Information
Article History
Accepted: 2 December 2024
First Online: 3 January 2025
Competing interests
: B.J.M. has acted as a consultant for Daiichi Sankyo, the GOG foundation, Genentech, Genmab, Iovance, Merck, Pfizer, Regeneron, Roche, and Seagen and has received speaker’s bureau from Daiichi Sankyo and Merck. K.S.T. has acted as a consultant for AstraZeneca, Eisai, Genmab, GSK, Karyopharm, Merck, Pfizer, Regeneron and Seagen, has served on advisory boards for AstraZeneca, Eisai, Genentech, Genmab, GSK, Karyopharm, Merck, Pfizer, Regeneron, and Seagen, and has received speaker’s bureau from AstraZeneca, Eisai, GSK, Merck and Seagen. A.A.F. declares no competing interests.
